The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second ...

Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as mirikizumab-mrkz, for the treatment of ...

Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh ...

The expected boost from the Gazprom arbitral award will be reflected in OMV’s Gas Marketing & Power unit’s results.

Tens of thousands of people worldwide could die prematurely before the end of the century due to extreme temperatures caused by the total ...